What is the recommended dose of Amoxiclav (amoxicillin/clavulanate) for treating bacterial infections?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Amoxicillin-Clavulanate (Amoxiclav) Dosing

For adults with respiratory tract infections or moderate-to-severe bacterial infections, prescribe amoxicillin-clavulanate 875 mg/125 mg twice daily as the standard dose, or escalate to 2000 mg/125 mg twice daily when antibiotic resistance is likely or infection severity warrants higher dosing. 1, 2, 3

Standard Adult Dosing

  • 875 mg/125 mg twice daily is the recommended dose for acute bacterial rhinosinusitis, community-acquired pneumonia, acute exacerbations of chronic bronchitis, and skin/soft tissue infections 2, 3
  • For mild-to-moderate infections, 500 mg/125 mg three times daily provides adequate coverage 2
  • Animal or human bite infections require 875 mg/125 mg twice daily for 5-7 days 4
  • The medication may be taken without regard to meals, though absorption of clavulanate is enhanced when taken at the start of a meal, which also minimizes gastrointestinal intolerance 3

High-Dose Adult Formulations

Use 2000 mg/125 mg twice daily when any of the following risk factors are present 1, 2:

  • Recent antibiotic use (within the past 30 days)
  • Geographic regions with >10% prevalence of penicillin-nonsusceptible Streptococcus pneumoniae
  • Severe infection (frontal or sphenoidal sinusitis, moderate-to-severe pneumonia)
  • Age >65 years
  • Recent hospitalization or close contact with healthcare environments
  • Immunocompromised status or significant comorbidities (diabetes, chronic heart/lung/liver/kidney disease)
  • Smoking or household exposure to smoke
  • Close contact with daycare facilities
  • History of recurrent infections or prior antibiotic therapy failure

This high-dose formulation achieves adequate serum concentrations to eradicate S. pneumoniae with amoxicillin MICs up to 4-8 mg/L 1, 5

Pediatric Dosing

Standard dose: 45 mg/kg/day of amoxicillin component divided twice daily (or 40 mg/kg/day divided three times daily for less severe infections) 1, 2

High-dose: 90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanate in two divided doses for 6, 1, 2:

  • Acute bacterial rhinosinusitis
  • Acute otitis media in children who received amoxicillin in the previous 30 days or with otitis-conjunctivitis
  • Suspected resistant infections

For children <12 weeks, use 25 mg/kg/day every 12 hours or 20 mg/kg/day every 8 hours 1

Duration of Therapy

  • Respiratory tract infections: 7-10 days 1
  • Acute bacterial rhinosinusitis (adults): 5-7 days 1
  • Acute bacterial rhinosinusitis (children): 10-14 days 2
  • Skin and soft tissue infections: 5-7 days after clinical improvement 4
  • Uncomplicated urinary tract infections: 3-7 days 1
  • Community-acquired pneumonia: 7-10 days, may extend to 14 days based on clinical response 1

Intravenous Dosing

  • Moderate-to-severe community-acquired pneumonia: 1.2 g IV every 8 hours 4
  • Intra-abdominal infections (non-critically ill, adequate source control): 2 g/0.2 g IV every 8 hours 1, 4
  • Pediatric IV dosing: 30 mg/kg three times daily, increase to four times daily in severe infections for patients >3 months 1

Renal Dosing Adjustments

  • Patients with glomerular filtration rate <30 mL/min should not receive the 875 mg dose 3
  • Dose reduction is generally not required unless renal impairment is severe 3

Critical Dosing Pitfalls to Avoid

  • Do not underdose in high-resistance areas—always use high-dose formulations (2000 mg/125 mg twice daily for adults or 90 mg/kg/day for children) when penicillin-resistant S. pneumoniae prevalence exceeds 10% 1
  • Avoid macrolides and trimethoprim-sulfamethoxazole as first-line therapy due to high resistance rates 2
  • Do not use fluoroquinolones as first-line in non-penicillin-allergic patients despite comparable efficacy, due to higher adverse event rates and need for antimicrobial stewardship 2
  • Evaluate clinical response within 48-72 hours of initiating therapy to determine need for alternative management 1
  • Complete the full treatment course to prevent treatment failure and resistance development 2

Penicillin-Allergic Patients

For patients with penicillin allergy, use doxycycline 100 mg twice daily or respiratory fluoroquinolones (levofloxacin 750 mg daily or moxifloxacin 400 mg daily) instead 2

References

Guideline

Amoxicillin-Clavulanate Dosage and Administration

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Amoxicillin-Clavulanate Dosing Guidelines for Bacterial Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Augmentin Dosage and Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.